Loading...
Market
Will PresVu eye drops receive approval for sale in at least two additional countries by end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from regulatory bodies or ENTOD Pharmaceuticals
Story
DCGI Approves ENTOD Pharmaceuticals' PresVu Eye Drops to Reduce Dependency on Reading Glasses
Sep 4, 2024, 03:40 AM
The Drug Controller General of India (DCGI) has approved new eye drops developed by ENTOD Pharmaceuticals, designed to reduce the dependency on reading glasses for individuals with presbyopia. The eye drops, named PresVu, have been under deliberation for over two years before receiving final approval. This marks India’s first eye drops aimed at eliminating the need for reading glasses.
View original story
Similar markets
Yes • 50%
No • 50%
Less than 5 countries • 25%
5 to 10 countries • 25%
11 to 20 countries • 25%
More than 20 countries • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0-5 new countries • 25%
6-10 new countries • 25%
11-15 new countries • 25%
More than 15 new countries • 25%
Yes • 50%
No • 50%
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
Less than 10 • 25%
10 to 20 • 25%
20 to 30 • 25%
More than 30 • 25%
Yes • 50%
No • 50%
More than 20 countries • 33%
10 to 20 countries • 34%
Less than 10 countries • 33%